Co-Producer
|
|
|
|
*
- may be subscription-only |
|
- BioCentriq: Partners With Orchestra Life Sciences
to Advance Princeton, NJ Cell Therapy Facility
Development More
- Context Therapeutics: First Patient Dosed in the
Phase 1 Clinical Trial of CTIM-76 More
- Taiho Oncology: Decitabine and Cedazuridine to be
Included in NIH Precision Medicine Trials More
- UroGen: ENVISION Trial Results Published in the
February Issue of The Journal of Urology Highlight
UGN-102 Achievement of 82.3% Duration of Response at
12 Months Paving the Way for the Potential First
FDA-Approved Treatment for LG-IR-NMIBC in June 2025 More
- Windtree:
Strengthens Global Intellectual Property Portfolio
With New Japanese Patent For the Company’s Oncology
Pipeline More
|
|
|
Section
Sponsor:
|
|
|
|
|
- Certara: Preliminary Fourth Quarter and Full Year
2024 Financial Results More
- More on Spark Therapeutics Co-Founder Being Back at
the Helm of a Philadelphia Gene Therapy Company More*
- Optinose: Preliminary Unaudited Fourth Quarter 2024
XHANCE Net Revenue of $22.4 Million More
|
|
|
Section
Sponsor:
|
|
|
|
|
- Join Big4Bio CBO Dave Whelan in Munich for DxPx;
Save With a Special Discount Code! More
- Penn: Unlocking the Brain - Peptide-Guided
Nanoparticles Deliver mRNA to Neurons More
- Subscribe to LifeSci Startup for Updates on
US Startups More
|
|
|
Section
Sponsor:
|
|
|
|
SECTION SPONSOR: |
|
|
|
- Big4Bio:Philadelphia Life Science Company
Directory More
|
NOTE:
EVENTS AND JOBS ARE FROM ALL BIG4BIO REGIONS
|
|
|
|
|
|
Section
Sponsor:
|
|
|
|
|
- OPPORTUNITY: Senior Director, Integrated Marketing
& Communications - Remote More
- OPPORTUNITY: Clinical Development Leader - New York,
NY More
- OPPORTUNITY: Sales Executive - Hybrid More
- OPPORTUNITY: Senior Director of Business Development
- Remote More
- OPPORTUNITY: Vice President of North America Medical
Affairs - MA More
- OPPORTUNITY: Vice President of Sales &
Marketing, North America - Remote More
|
|
|
Section
Sponsor:
|
|
|
|
|